Add to ORKGAcquired immunodeficiency syndrome (AIDS) and its associated gastrointestinal complications may impair the absorption of antituberculosis drugs, which results in subsequent treatment failure. We evaluated the effects of human immunodeficiency virus (HIV) on the pharmacokinetics of antituberculosis drugs by measuring blood levels of rifampicin and isoniazid in patients with advanced HIV disease and diarrhea with and without tuberculosis
The aim of this study was to compare the pharmacokinetics of antituberculosis drugs in patients with...
For drug-compliant patients, poor responses to tuberculosis (TB) treatment might be attributable to ...
A placebo-controlled trial that compares the outcomes of immediate vs. deferred initiation of antire...
We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antitu...
The absorption of rifampin, isoniazid, and D-xylose in patients with human immunodeficiency virus (...
We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antitu...
Background & Objective: AIDS and its associated gastrointestinal complications may impair the ab...
INTRODUCTION: Contrasting findings have been published regarding the effect of human immunodeficienc...
The absorption of rifampin, isoniazid, and D-xylose in patients with human immunodeficiency virus (H...
Limited data address the impact of HIV coinfection on the pharmacokinetics (PK) of antituberculosis ...
Background. We explored the association between antituberculosis drug pharmacokinetics and treatment...
Background & objectives: AIDS and its associated gastrointestinal complications may impair the absor...
A placebo-controlled trial that compares the outcomes of immediate versus deferred initiation of ant...
There are contrasting data in the literature about antituberculosis plasma drug concentrations in HI...
Objectives: To describe the pharmacokinetics of isoniazid and acetyl-isoniazid in TB/HIV-coinfected ...
The aim of this study was to compare the pharmacokinetics of antituberculosis drugs in patients with...
For drug-compliant patients, poor responses to tuberculosis (TB) treatment might be attributable to ...
A placebo-controlled trial that compares the outcomes of immediate vs. deferred initiation of antire...
We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antitu...
The absorption of rifampin, isoniazid, and D-xylose in patients with human immunodeficiency virus (...
We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antitu...
Background & Objective: AIDS and its associated gastrointestinal complications may impair the ab...
INTRODUCTION: Contrasting findings have been published regarding the effect of human immunodeficienc...
The absorption of rifampin, isoniazid, and D-xylose in patients with human immunodeficiency virus (H...
Limited data address the impact of HIV coinfection on the pharmacokinetics (PK) of antituberculosis ...
Background. We explored the association between antituberculosis drug pharmacokinetics and treatment...
Background & objectives: AIDS and its associated gastrointestinal complications may impair the absor...
A placebo-controlled trial that compares the outcomes of immediate versus deferred initiation of ant...
There are contrasting data in the literature about antituberculosis plasma drug concentrations in HI...
Objectives: To describe the pharmacokinetics of isoniazid and acetyl-isoniazid in TB/HIV-coinfected ...
The aim of this study was to compare the pharmacokinetics of antituberculosis drugs in patients with...
For drug-compliant patients, poor responses to tuberculosis (TB) treatment might be attributable to ...
A placebo-controlled trial that compares the outcomes of immediate vs. deferred initiation of antire...